Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LB0X
|
|||
Former ID |
DIB018009
|
|||
Drug Name |
KH064
|
|||
Synonyms |
sPLA2-2A inhibitor, compound 2b
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Clinical trial | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C31H37NO4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)NC(CCC(=O)O)CC2=CC=C(C=C2)OCC3=CC=CC=C3
|
|||
InChI |
1S/C31H37NO4/c33-30(16-10-2-1-5-11-25-12-6-3-7-13-25)32-28(19-22-31(34)35)23-26-17-20-29(21-18-26)36-24-27-14-8-4-9-15-27/h3-4,6-9,12-15,17-18,20-21,28H,1-2,5,10-11,16,19,22-24H2,(H,32,33)(H,34,35)/t28-/m0/s1
|
|||
InChIKey |
KWLUIYFCMHKLKY-NDEPHWFRSA-N
|
|||
CAS Number |
CAS 393569-31-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Group IIA phospholipase A2 (GIIA sPLA2) | Target Info | Inhibitor | [1] |
BioCyc | Phospholipases | |||
KEGG Pathway | Glycerophospholipid metabolism | |||
Ether lipid metabolism | ||||
Arachidonic acid metabolism | ||||
Linoleic acid metabolism | ||||
alpha-Linolenic acid metabolism | ||||
Metabolic pathways | ||||
Ras signaling pathway | ||||
Vascular smooth muscle contraction | ||||
Pancreatic secretion | ||||
Fat digestion and absorption | ||||
Pathway Interaction Database | Glypican 1 network | |||
Reactome | Acyl chain remodelling of PC | |||
Acyl chain remodelling of PE | ||||
Acyl chain remodelling of PI | ||||
WikiPathways | Cardiac Hypertrophic Response | |||
Glycerophospholipid biosynthesis | ||||
Glycerophospholipid Biosynthetic Pathway | ||||
Spinal Cord Injury | ||||
Eicosanoid Synthesis | ||||
MicroRNAs in cardiomyocyte hypertrophy |
References | Top | |||
---|---|---|---|---|
REF 1 | D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity. Chembiochem. 2003 Mar 3;4(2-3):181-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.